These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1840 related items for PubMed ID: 26557010
1. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology. Andersen V, Svenningsen K, Knudsen LA, Hansen AK, Holmskov U, Stensballe A, Vogel U. World J Gastroenterol; 2015 Nov 07; 21(41):11862-76. PubMed ID: 26557010 [Abstract] [Full Text] [Related]
2. High ABCC2 and low ABCG2 gene expression are early events in the colorectal adenoma-carcinoma sequence. Andersen V, Vogel LK, Kopp TI, Sæbø M, Nonboe AW, Hamfjord J, Kure EH, Vogel U. PLoS One; 2015 Nov 07; 10(3):e0119255. PubMed ID: 25793771 [Abstract] [Full Text] [Related]
3. Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study. Kopp TI, Andersen V, Tjonneland A, Vogel U. Scand J Gastroenterol; 2015 Nov 07; 50(12):1469-81. PubMed ID: 26109419 [Abstract] [Full Text] [Related]
4. Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta. Neumanova Z, Cerveny L, Ceckova M, Staud F. AIDS; 2014 Jan 02; 28(1):9-17. PubMed ID: 24413260 [Abstract] [Full Text] [Related]
5. Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1). Englund G, Jacobson A, Rorsman F, Artursson P, Kindmark A, Rönnblom A. Inflamm Bowel Dis; 2007 Mar 02; 13(3):291-7. PubMed ID: 17206689 [Abstract] [Full Text] [Related]
6. ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases. Fischer S, Lakatos PL, Hungarian IBD Study Group, Lakatos L, Kovacs A, Molnar T, Altorjay I, Papp M, Szilvasi A, Tulassay Z, Osztovits J, Papp J, Demeter P, Schwab R, Tordai A, Andrikovics H. Scand J Gastroenterol; 2007 Jun 02; 42(6):726-33. PubMed ID: 17505995 [Abstract] [Full Text] [Related]
7. Polymorphisms of the drug transporters ABCB1, ABCG2, ABCC2 and ABCC3 and their impact on drug bioavailability and clinical relevance. Bruhn O, Cascorbi I. Expert Opin Drug Metab Toxicol; 2014 Oct 02; 10(10):1337-54. PubMed ID: 25162314 [Abstract] [Full Text] [Related]
8. Expression and activity of the efflux transporters ABCB1, ABCC2 and ABCG2 in the human colorectal carcinoma cell line LS513. Salphati L, Plise EG, Li G. Eur J Pharm Sci; 2009 Jun 28; 37(3-4):463-8. PubMed ID: 19491037 [Abstract] [Full Text] [Related]
9. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Albermann N, Schmitz-Winnenthal FH, Z'graggen K, Volk C, Hoffmann MM, Haefeli WE, Weiss J. Biochem Pharmacol; 2005 Sep 15; 70(6):949-58. PubMed ID: 16054595 [Abstract] [Full Text] [Related]
10. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Leslie EM, Deeley RG, Cole SP. Toxicol Appl Pharmacol; 2005 May 01; 204(3):216-37. PubMed ID: 15845415 [Abstract] [Full Text] [Related]
11. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function. Teng YN, Sheu MJ, Hsieh YW, Wang RY, Chiang YC, Hung CC. Phytomedicine; 2016 Mar 15; 23(3):316-23. PubMed ID: 26969385 [Abstract] [Full Text] [Related]
12. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance. Shi Z, Peng XX, Kim IW, Shukla S, Si QS, Robey RW, Bates SE, Shen T, Ashby CR, Fu LW, Ambudkar SV, Chen ZS. Cancer Res; 2007 Nov 15; 67(22):11012-20. PubMed ID: 18006847 [Abstract] [Full Text] [Related]
13. High-activity p-glycoprotein, multidrug resistance protein 2, and breast cancer resistance protein membrane vesicles prepared from transiently transfected human embryonic kidney 293-epstein-barr virus nuclear antigen cells. Karlsson JE, Heddle C, Rozkov A, Rotticci-Mulder J, Tuvesson O, Hilgendorf C, Andersson TB. Drug Metab Dispos; 2010 Apr 15; 38(4):705-14. PubMed ID: 20071452 [Abstract] [Full Text] [Related]
14. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387. Durmus S, Xu N, Sparidans RW, Wagenaar E, Beijnen JH, Schinkel AH. Pharmacol Res; 2013 Oct 15; 76():9-16. PubMed ID: 23827160 [Abstract] [Full Text] [Related]
15. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Limtrakul P, Chearwae W, Shukla S, Phisalphong C, Ambudkar SV. Mol Cell Biochem; 2007 Feb 15; 296(1-2):85-95. PubMed ID: 16960658 [Abstract] [Full Text] [Related]
16. Zinc finger nuclease-mediated gene knockout results in loss of transport activity for P-glycoprotein, BCRP, and MRP2 in Caco-2 cells. Sampson KE, Brinker A, Pratt J, Venkatraman N, Xiao Y, Blasberg J, Steiner T, Bourner M, Thompson DC. Drug Metab Dispos; 2015 Feb 15; 43(2):199-207. PubMed ID: 25388687 [Abstract] [Full Text] [Related]
17. Ezrin regulates the expression of Mrp2/Abcc2 and Mdr1/Abcb1 along the rat small intestinal tract. Nakano T, Sekine S, Ito K, Horie T. Am J Physiol Gastrointest Liver Physiol; 2013 Dec 15; 305(11):G807-17. PubMed ID: 24091598 [Abstract] [Full Text] [Related]
18. Effect of ceritinib (LDK378) on enhancement of chemotherapeutic agents in ABCB1 and ABCG2 overexpressing cells in vitro and in vivo. Hu J, Zhang X, Wang F, Wang X, Yang K, Xu M, To KK, Li Q, Fu L. Oncotarget; 2015 Dec 29; 6(42):44643-59. PubMed ID: 26556876 [Abstract] [Full Text] [Related]
19. Lipid regulation of the ABCB1 and ABCG2 multidrug transporters. Hegedüs C, Telbisz Á, Hegedűs T, Sarkadi B, Özvegy-Laczka C. Adv Cancer Res; 2015 Dec 29; 125():97-137. PubMed ID: 25640268 [Abstract] [Full Text] [Related]
20. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Dai CL, Tiwari AK, Wu CP, Su XD, Wang SR, Liu DG, Ashby CR, Huang Y, Robey RW, Liang YJ, Chen LM, Shi CJ, Ambudkar SV, Chen ZS, Fu LW. Cancer Res; 2008 Oct 01; 68(19):7905-14. PubMed ID: 18829547 [Abstract] [Full Text] [Related] Page: [Next] [New Search]